Cyclic progesterone and spironolactone treatment for androgenic polycystic ovary syndrome
PCOS > Treatment > Cyclic Progesterone TherapyPCOS > Treatment > Anti-Androgen TherapyRRM Methods > Hormonal Treatment > Progesterone Protocols
The central role of ovulatory disturbances in the etiology of androgenic polycystic ovary syndrome (PCOS)—Evidence for treatment with cyclic progesterone
- Vancouver Hospital and Health Sciences Centre ROR
- University of British Columbia, Vancouver, BC, Canada ROR
Drug Discovery Today: Disease Models, 32, 71-82
Abstract
No abstract available for this article.
Topics
Cite this article
Lara Briden, Sonia Shirin, & Jerilynn C Prior (2020). The central role of ovulatory disturbances in the etiology of androgenic polycystic ovary syndrome (PCOS)—Evidence for treatment with cyclic progesterone. *Drug Discovery Today: Disease Models*, *32*, 71-82. https://doi.org/10.1016/j.ddmod.2020.11.008
Lara Briden, Sonia Shirin, Jerilynn C Prior. The central role of ovulatory disturbances in the etiology of androgenic polycystic ovary syndrome (PCOS)—Evidence for treatment with cyclic progesterone. Drug Discovery Today: Disease Models. 2020;32:71-82. doi:10.1016/j.ddmod.2020.11.008
Lara Briden, et al. "The central role of ovulatory disturbances in the etiology of androgenic polycystic ovary syndrome (PCOS)—Evidence for treatment with cyclic progesterone." *Drug Discovery Today: Disease Models*, vol. 32, 2020, pp. 71-82.